Elon's Vision
  • Contacts
  • Privacy Policy
  • Terms & Conditions
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
Elon's Vision
No Result
View All Result
Home Stock

New software platforms for microbiology clinical genotyping – ABL Diagnostics introduces latest versions of DeepChek®, ViroScore®, and MicrobioChek®

by
January 3, 2024
in Stock
0
0
SHARES
6
VIEWS
Share on FacebookShare on Twitter

ABL Diagnostics, a Euronext-listed company specializing in molecular biology assays and software for microbiology laboratories, has announced the release of new versions of its CE-IVD DeepChek® and ViroScore® software applications. These web-based and highly secure downstream analysis platforms are tailored to analyze Next Generation Sequencing (NGS) and Capillary Electrophoresis (SANGER) data…

Source

Previous Post

Maximising Efficiency and Productivity: The Critical Role of Outsourced IT Support for Businesses

Next Post

2035 UK Solar Goal Destroyed by Soaring Expenses and Traffic Standstill

Next Post

2035 UK Solar Goal Destroyed by Soaring Expenses and Traffic Standstill

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!
  • Trending
  • Comments
  • Latest

Jay Bhattacharya on Public Health

October 12, 2021

That Bangladesh Mask Study!

December 1, 2021

Microsoft Planner vs Trello: Which Project Management Tool is Better?

May 24, 2023

Antitrust Regulation Assumes Bureaucrats Know the “Correct” Amount of Competition

November 24, 2021

Discover the World of Crystals and Unlock Your Clair Senses at the Mind Body Spirit Festival in Birmingham’s NEC

0

0

0

0

Discover the World of Crystals and Unlock Your Clair Senses at the Mind Body Spirit Festival in Birmingham’s NEC

October 23, 2025
London Stock Exchange seals £170m deal with 11 global banks to strengthen post-trade operations

London Stock Exchange seals £170m deal with 11 global banks to strengthen post-trade operations

October 23, 2025
Tony Blair urges Ed Miliband to scrap green levies amid energy cost backlash

Tony Blair urges Ed Miliband to scrap green levies amid energy cost backlash

October 23, 2025
Oxford rail link to reopen as £10bn tech campus fuels ‘Europe’s Silicon Valley’ vision

Oxford rail link to reopen as £10bn tech campus fuels ‘Europe’s Silicon Valley’ vision

October 23, 2025

Recent News

Discover the World of Crystals and Unlock Your Clair Senses at the Mind Body Spirit Festival in Birmingham’s NEC

October 23, 2025
London Stock Exchange seals £170m deal with 11 global banks to strengthen post-trade operations

London Stock Exchange seals £170m deal with 11 global banks to strengthen post-trade operations

October 23, 2025
Tony Blair urges Ed Miliband to scrap green levies amid energy cost backlash

Tony Blair urges Ed Miliband to scrap green levies amid energy cost backlash

October 23, 2025
Oxford rail link to reopen as £10bn tech campus fuels ‘Europe’s Silicon Valley’ vision

Oxford rail link to reopen as £10bn tech campus fuels ‘Europe’s Silicon Valley’ vision

October 23, 2025

Disclaimer: ElonsVision.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

  • Contacts
  • Privacy Policy
  • Terms & Conditions

Copyright © 2025 ElonsVision. All Rights Reserved.

No Result
View All Result
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock

Copyright © 2025 ElonsVision. All Rights Reserved.